ArticleJournal of cellular and molecular medicine2020

Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple-negative breast cancer.

Verónica Corrales-Sánchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.